Develop a computer based model that identifies novel drug or drug combinations for Early T precursor (ETP) type acute lymphoblastic leukemia a type of blood cancer.
Not Applicable
- Conditions
- Health Condition 1: null- T-cell acute lymphoblastic leukemia (T-ALL)
- Registration Number
- CTRI/2018/02/011823
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Samples from patients diagnosed with ETP-ALL as defined by flow cytometry evidence of lymphoblasts expressing absence of CD1a and CD8, weak CD5 expression, and the expression of one or more myeloid or stem cell-associated markers
Exclusion Criteria
Not Applicable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method